arrow_back Back Filing freshness 20-F FY 2025 SEC EDGAR

PRF Technologies Ltd.

PRFX
$1.04 ▼ -0.08 (-7.14%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
9 Visible periods
22 Metrics
Peer-ranked Benchmarks
Price Chart
26
Health
Poor
Bearish
auto_awesome

Analytical Summary

PRF Technologies Ltd. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth
Op. Margin
ROIC -60.1%
FCF / Share $-6.11
Trailing P/E
Price / Book 0.1x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

9-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$17.00K
Net Income Profit after all expenses
$-5.02M
↑ +65.6%
FCF / Share Free cash flow per share
$-6.11
↑ +93.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
15
Cash Quality
53

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 9 quarters